Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06335810 · ClinicalTrials.gov registry record · NA
Reducing Obesity Using Social Ties Program
A NA study of Obesity, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 264
- Enrollment target
- 1
- Study location
NCT06335810: Recruiting NA study of Obesity, sponsored by Weill Medical College of Cornell University.
NCT06335810 is a NA study of Obesity that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 264 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06335810, a NA study of Obesity, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 264 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial aims to test the feasibility and acceptability of addressing interpersonal barriers to weight-related behavior change. Specifically, the study will test if, by including up to two friends, family members, or co-workers in a lifestyle intervention for weight loss, the person enrolled in the study loses more weight than someone whose friends, family members, or co-workers were not invited to participate.
Conditions Studied
Interventions
- BEHAVIORAL Social Network Intervention
- BEHAVIORAL Individual Lifestyle Intervention
- OTHER Social Network Member
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What NCT06335810 shows while recruiting
NCT06335810 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Social Network Intervention is the first listed.
NCT06335810 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06335810 about?
NCT06335810 is a clinical study titled "Reducing Obesity Using Social Ties Program". This trial aims to test the feasibility and acceptability of addressing interpersonal barriers to weight-related behavior change. Specifically, the study will test if, by including up to two friends, family members, or co-workers in a lifestyle intervention for weight loss, the person enrolled in th...
What is the current status of trial NCT06335810?
This trial is currently recruiting. It is a NA study. The enrollment target is 264 participants. The study started on 2024-04-05. Estimated completion is 2026-03-01.
What conditions does trial NCT06335810 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT06335810?
The interventions under investigation include: Social Network Intervention (BEHAVIORAL), Individual Lifestyle Intervention (BEHAVIORAL), Social Network Member (OTHER).
Who is sponsoring clinical trial NCT06335810?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06335810 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06335810's enrollment target sits among peer trials
264 246th of 1053 higher than 807 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04295863 · 264 participants · Phase 1
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
- NCT05220202 · 264 participants · NA
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
- NCT05473013 · 264 participants · NA
Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
- NCT05858346 · 264 participants · NA
Comparing TBT to Disorder-Specific Psychotherapy in Veterans With Social Anxiety Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI